SCHEMBL6566909

SCHEMBL6566909

COc1ccc(NC(=O)NC(C)(C)CC(C)(C)C)cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
MAPT P10636 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
POLB P06746 2/20 0.51
HTT P42858 2/20 0.51
TRPV1 Q8NER1 1/20 0.48
GAA P10253 3/20 0.47
ALDH1A1 P00352 2/20 0.47
TP53 P04637 2/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
IMPDH2 P12268 1/20 0.46
IMPDH1 P20839 1/20 0.46
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
PKM P14618 1/20 0.41
IDO1 P14902 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567544 0.86 POLB (0.56) KMT2AMEN1MAPTSMN1; SMN2POLB
SCHEMBL6649644 0.85 EPHX2 (0.58) MAPTALDH1A1HPGDNPSR1
SCHEMBL6568629 0.85 IMPDH2 (0.58) KMT2AMEN1MAPTSMN1; SMN2HTT
SCHEMBL4344564 0.78 HTT (0.53) KMT2AMEN1MAPTSMN1; SMN2POLB
SCHEMBL4358325 0.78 POLB (0.60) KMT2AMEN1MAPTSMN1; SMN2POLB
SCHEMBL11676119 0.76 HTT (0.63) KMT2AMEN1MAPTSMN1; SMN2POLB
SCHEMBL4345612 0.75 HTT (0.66) KMT2AMEN1MAPTSMN1; SMN2POLB
SCHEMBL6565514 0.75 POLB (0.66) KMT2AMEN1MAPTSMN1; SMN2POLB
SCHEMBL7284429 0.74 TUBB4A (0.59) KMT2AMEN1SMN1; SMN2POLBTRPV1
SCHEMBL4689726 0.74 ALDH1A1 (0.58) KMT2AMEN1MAPTSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed